Press releases

Quantum Surgical receives a €200 000 “Pass Rebond” Grant from the Occitanie Region

Published on
September 22, 2020
Press Contact

Montpellier, France, Tuesday, September 22, 2020 – Quantum Surgical, an innovative company developing a robotic platform for the early treatment of liver cancer, announces that it has been awarded a €200,000 grant from the Occitanie Region.

This investment grant, awarded as part of the regional support plan for businesses known as the “Pass Rebond Occitanie,” is intended to support company development projects in anticipation of economic recovery following the Covid-19 health crisis.

The funding will enable the company to implement an Enterprise Resource Planning (ERP) system, which is essential for the upcoming market launch of its first product aimed at treating liver tumor lesions.

“We are extremely grateful for the support provided to businesses by the Occitanie Region, especially during this health crisis. This grant will allow us to continue developing our robotic platform, which is scheduled to be launched in 2021,” said Christophe Sibillin, Chief Financial Officer of Quantum Surgical.

The future of minimally invasive cancer treatment is today.